Data / Form D filings / Edison Pharmaceuticals Inc
Edison Pharmaceuticals Inc: Form D filings
Edison Pharmaceuticals Inc, a biotechnology company in Mountain View, CA, filed 6 Form D notices with the SEC between 2009 and 2014. The latest, on March 27, 2014, reports $50 million sold of a $100 million offering to 1 investor.
Find out what Edison Pharmaceuticals Inc does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 350 NO. BERNARDO AVE., Mountain View, CA, 94043
- Phone
- (650) 641-9200
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1346136
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 27, 2014 | New notice | $100,000,270 | $50,000,135 | $50,000,135 | 1 | Mar 20, 2014 | sec.gov |
| Nov 26, 2012 | New notice | $34,999,992 | $20,049,916 | $14,950,076 | 6 | Nov 13, 2012 | sec.gov |
| Aug 31, 2011 | New notice | $25,250,016 | $4,082,386 | $21,167,630 | 4 | Aug 29, 2011 | sec.gov |
| Aug 25, 2010 | New notice | $10,001,368 | $250,026 | $9,751,342 | 1 | Aug 18, 2010 | sec.gov |
| Apr 15, 2010 | New notice | $7,499,975 | $3,024,907 | $4,475,068 | 6 | Apr 5, 2010 | sec.gov |
| Apr 23, 2009 | New notice | $8,000,000 | $2,753,514 | $5,246,486 | 13 | Apr 21, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Forrest Sawyer | Director | |
| Carl Berg | Director | |
| Guy Miller | Executive Officer, Director | |
| Taro Inaba | Director |
Other biotechnology companies in California that filed recently
- CARI Health, Inc. $280,000 · Nov 6, 2026
- Ausel, Inc. $120,000 · Nov 4, 2026
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
- Tempest Therapeutics, Inc. $7.5 million · Oct 14, 2026
- Lionheart Health, Inc. $387,500 · Oct 7, 2026
- Rakuten Medical, Inc. $9 million · Oct 6, 2026
- Zonaliz, Inc. $2.5 million · Oct 5, 2026
- Altay Therapeutics, Inc. $15.7 million · Oct 2, 2026
- Sialia Therapeutics, Inc. $1.5 million · Sep 29, 2026
- Vetmab Biosciences, Inc. $11.4 million · Sep 29, 2026
Every Form D from the week of Mar 24, 2014 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Edison Pharmaceuticals Inc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.